The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. ORIC Pharmaceuticals Inc shares valued at $159,719 were sold by Piscitelli Dominic on Oct 06 ’25. At $14.52 per share, Piscitelli Dominic sold 11,000 shares. The insider’s holdings dropped to 48,317 shares worth approximately $0.55 million following the completion of this transaction.
Also, Chacko Jacob sold 37,461 shares, netting a total of over 461,520 in proceeds. Following the sale of shares at $12.32 each, the insider now holds 531,419 shares.
Before that, Dominic Piscitelli had added 50,000 shares to its account. In a trade valued at $725,000, the Officer bought ORIC Pharmaceuticals Inc shares for $14.50 each.
As published in their initiating research note from Evercore ISI on November 20, 2025, ORIC Pharmaceuticals Inc [ORIC] has been an Outperform and the price target has been revised to $25. Analysts at Wolfe Research started covering the stock with ‘”a Peer perform”‘ outlook in a report released in mid November. Earlier on July 08, 2025, Ladenburg Thalmann initiated its rating. Their recommendation was “a Buy” for ORIC stock.
Analyzing ORIC Stock Performance
The stock’s lowest price that day was $11.32, but it reached a high of $12.5 in the same session. During the last five days, there has been a drop of approximately -5.82%. Over the course of the year, ORIC Pharmaceuticals Inc shares have jumped approximately 34.11%. Shares of the company reached a 52-week high of $14.93 on 10/07/25 and a 52-week low of $3.90 on 04/09/25.
Support And Resistance Levels for ORIC Pharmaceuticals Inc (ORIC)
According to the 24-hour chart, there is a support level at 10.96, which, if violated, would cause prices to drop to 10.44. In the upper region, resistance lies at 12.25. The next price resistance is at 13.02. RSI (Relative Strength Index) is 38.76 on the 14-day chart, showing neutral technical sentiment.
Is ORIC Pharmaceuticals Inc subject to short interest?
Stocks of ORIC Pharmaceuticals Inc saw a sharp rise in short interest on 2025-10-31 jumping by 4.25 million shares to 15.49 million. Data from Yahoo Finance shows that the short interest on 2025-09-30 was 11.24 million shares. A jump of 27.44% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 10.75 of the overall float, the days-to-cover ratio (short ratio) jumped to 10.75.
Which companies own the most shares of ORIC Pharmaceuticals Inc (ORIC)?
In terms of ORIC Pharmaceuticals Inc share price expectations, FactSet research, analysts set an average price target of 20.5 in the next 12 months, up nearly 78.57% from the previous closing price of $11.48. Analysts anticipate ORIC Pharmaceuticals Inc stock to reach 23 by 2025, with the lowest price target being 18. In spite of this, 5 analysts ranked ORIC Pharmaceuticals Inc stock as Buy at the end of 2025. On October 31, 2024, Wells Fargo assigned a price target of “an Overweight” to the stock and initiated coverage with a $20.
